GSK-239512
CAS: 720691-69-0
Ref. 3D-VDB69169
| 1g | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
GSK-239512 is a clinical candidate for the treatment of chronic inflammatory diseases. It is a potent antagonist of the IL-6 receptor and has been shown to have immunomodulatory effects in preclinical models. GSK-239512 has been studied in an oral chronic toxicity study in rats at doses of up to 600 mg/kg/day for 18 months, with no evidence of any toxic effect. The drug was not found to cross the blood-brain barrier or cause any effect on the central nervous system. In molecular modeling studies, GSK-239512 was found to bind to IL-6 receptors and block signaling pathways associated with inflammation, including those that lead to neutrophil recruitment, endothelial activation and platelet aggregation.
GSK-239512 has been shown to be safe at doses up to 600 mg/kg/day in nonclinical studies and was well tolerated by animals at doses up to 600 mg/kg/day in a long term
Propiedades químicas
Consulta técnica sobre: 3D-VDB69169 GSK-239512
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
